PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

http://ww2.peerview.com

Eine durchschnittliche Folge dieses Podcasts dauert 1h1m. Bisher sind 810 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 33 days 12 hours 38 minutes

subscribe
share






Sagar Lonial, MD, FACP - Fueling Innovation in Multiple Myeloma: Thoughts From the Chair


Go online to PeerView.com/CSW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 23, 2020  35m
 
 

Brendon Stiles, MD - Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team


Go online to PeerView.com/WHA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 21, 2020  1h6m
 
 

William K. Oh, MD - Chair’s Take on Innovation in Prostate Cancer: Thoughts on New Evidence


Go online to PeerView.com/UPY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 18, 2020  36m
 
 

Harry P. Erba, MD, PhD - Advances in AML Care: Highlights From Recent Science


Go online to PeerView.com/VKE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 16, 2020  42m
 
 

Professor Florence Cymbalista, MD, PhD - Transforming Care With BTK Inhibitors in CLL: New Insights on Therapy Selection, Safety, and Agent Sequencing Across the Treatment Continuum


Go online to PeerView.com/QHM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 14, 2020  1h27m
 
 

Linda R. Duska, MD, MPH - Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances and Innovative Therapies in Endometrial and Cervical Cancers


Go online to PeerView.com/VSK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 11, 2020  34m
 
 

Bradley J. Monk, MD, FACS, FACOG - Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management


Go online to PeerView.com/VSY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 9, 2020  28m
 
 

David H. Ilson, MD, PhD - Chair's Take: HER2-Targeted and Other Agents for Gastric Cancer


Go online to PeerView.com/GZH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 7, 2020  34m
 
 

Suresh S. Ramalingam, MD, FACP, FASCO - Chair's Take: Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer


Go online to PeerView.com/WCZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 4, 2020  28m
 
 

Mitchell S. Cairo, MD - Achieving Consensus on Modern VOD/SOS Management: A Guide to Disease Recognition, Classification, and Treatment in Adults and Pediatric Patients


Go online to PeerView.com/KAS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 2, 2020  40m